A Flagship VentureLabs Company

Seres Therapeutics

215 First Street

Cambridge, MA  02142

Tel: 617.945.9626


Leadership:
Roger Pomerantz, MD
President & CEO


Website:
www.serestherapeutics.com


Information:
info@serestherapeutics.com

Seres Therapeutics

Flagship Partners:  Noubar Afeyan, David Berry
Initial Investment: 
2012
Status: 
Public

Seres Therapeutics (NASDAQ: MCRB) is a publicly traded leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome.

Noubar Afeyan is on the Board of Directors.